KAIROS PHARMA, LTD.
KAPAKey Metrics
ChartsSankeyProfileEarningsWatchlist
IncomeCash FlowBalanceKey Metrics
Q1 2026
Q1 2026
Q1 2026 isn't filed yet — showing through Q1 2026.

Key Metrics for KAIROS PHARMA, LTD.

Valuation

Valuation Multiples

Stock Price (FY-end)
$1
Market Cap
$13M
Enterprise Value
$9M

Yields

Per Share

Returns

WACC

Solvency & Liquidity

Working Capital

Earnings Quality

Forensics

Stock Performance